Amy W. Schulman
Chairman
Alnylam Pharmaceuticals, Inc. (ALNY)Board Member
Alnylam Pharmaceuticals, Inc. (ALNY)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Amy W. Schulman
Amy W. Schulman is recorded as Chairman and Board Member at Alnylam Pharmaceuticals, Inc. (ALNY). Alnylam Pharmaceuticals, Inc. reported in an 8-K filed January 6, 2023 that Amy W. Schulman was appointed Chair of the Board, effective January 5, 2023.
“Amy W. Schulman, the Lead Independent Director, has been appointed by the Board to serve as Chair of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-01-05–present
-
Current
2021-08-02–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Alnylam Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Yvonne Greenstreet CEO, COO
- Yvonne L. Greenstreet CEO, COO, Board Member
- Michael Bonney Chairman
- Michael W. Bonney Chairman
- Jeffrey Poulton CFO
- Manmeet S CFO
- Akshay K. Vaishnaw, M.D., Ph.D. CIO
- Benjamin F. Cravatt Board Member
- Benjamin F. Cravatt, Ph.D. Board Member
- Carolyn R. Bertozzi Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.